Vecuronium Bromide Injection IP

Trade Name: CureVBI
Available Strength : 10 mg
Available Combination : Vecuronium Bromide Injection IP is used in combination with general anesthesia to produce muscle relaxation during surgery and facilitate endotracheal intubation.
Packing : vial
Pack Insert/Leaflet : YES
Therapeutic use : Vecuronium Bromide Injection IP is a neuromuscular blocking agent used during general anesthesia to induce skeletal muscle relaxation. It facilitates endotracheal intubation and provides muscle paralysis during surgical procedures or mechanical ventilation, allowing safe and controlled surgery, without providing analgesia or sedation.
Capacity : 100000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.